Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) Readies Online Sales Strategy for New InterceptCS Cold Sore Prevention Device

• THRBF offers an IoT- and Bluetooth-enabled device for cold-sore prevention
• Its sales strategy is part of the company’s larger focus on developing products for the dermatology market
• THRBF’s proprietary technology is designed to prevent cold sores in the OTC sector, which is projected to record significant sales growth

Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) is offering a new generation of technology in the burgeoning skin care market. The company is specifically planning to target sales growth for its high gross-margin InterceptCS* cold sore prevention device with a new website, social media campaign and online sales strategy (http://nnw.fm/f5cvQ).

THRBF’s new InterceptCS is a class II medical device that works through three 30-second treatments and offers multi-use activators. Therma Bright’s strategy is to market the product online through distributors and a new social media campaign, as well as on its new website at www.ColdSores.com.

Toronto-based THRBF offers first-rate medical devices for dermatological needs. The company focuses on proprietary technology in the OTC pain-free and noninvasive sectors, and it has received class II medical device status from the U.S. Food and Drug Administration (FDA). Therma Bright also markets TherOZap, an insect-bite treatment device.

The dermatology market is estimated to reach $22.6 billion in the United States by 2028, according to GMR Data (http://nnw.fm/E5lYd).

* Based on a double-blind placebo study, InterceptCS is approved for the claim, “For prevention of cold sores when used within three hours of the onset of the prodrome,” by Health Canada. InterceptCS is not approved by the United States FDA for any claim of clinical indication, clinical efficac, and/or cure or prevention of disease.

For more information, visit the company’s website at www.ThermaBright.com

NOTE TO INVESTORS: The latest news and updates relating to THRBF are available in the company’s newsroom at http://nnw.fm/THRBF

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Launches Its Largest Cannabinoid Research Program

• The R&D program will focus on the proprietary Lexaria DehydraTECH delivery technology with the purpose of enhancing it further
• Results could contribute to new patent filings in the future; in addition, the program will examine more extensively the way DehydraTECH-enabled CBD outperforms generic CBD
• Lexaria-designed nanotech enhancements will also be included in the program

Biotechnology company and drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is launching its largest cannabinoid research and development program to date. The program consists of 11 separate animal studies, according to a company press release (http://nnw.fm/iY7Tv).

The Lexaria in vitro study design was conceptualized six months ago. Laboratory test articles have been produced and meet or exceed required quality control thresholds. The program has moved on to the implementation stage, which includes testing for a variety of performance-enhancing variations of the company’s DehydraTECH.

The DehydraTECH trademarked delivery technology is patented for cannabidiol (CBD) and tetrahydrocannabinoid (THC). The technology has a wide scope of applications, with evidence gathered separately of an ability to cross the blood-brain barrier, which could lead to applications related to nervous system conditions like Alzheimer’s disease.

Through the research, Lexaria aims to enhance the DehydraTECH drug delivery platform even further, with optimization enhancement designed to improve the platform’s performance in next-generation formulations currently under development.

As per the official Lexaria announcement, the research and development program could contribute to additional patent filings in the future. Thus, the company has limited information about the study’s design for the time being. The primary aim of the research, however, is to determine the mechanisms by which DehydraTECH-enabled CBD outperforms generic CBD – a fact that has already been established through multiple trials.

DehydraTECH and the other Lexaria technologies are already disrupting the cannabis edibles industry. These developments reduce the undesirable taste of CBD products, eliminate the need for the addition of sweeteners (simplifying the creation of sugar-free options), increase absorption rates and reduce the time of positive effect onset.

Lexaria-designed nanotech enhancements will also be included among the research and development program subjects. In the beginning of 2018, Lexaria evaluated a number of nanotech emulsions for use with DehydraTECH. These nano emulsions are expected to be tested in combination with the DehydraTECH delivery system for the first time ever.

Various nanotech solutions are already available on the market. No other company, however, has come up with a combination of nano emulsions and a drug delivery platform that’s patented for use with cannabinoids. Lexaria representatives believe that the combination enhances the individual performance characteristics of both technologies.

DehydraTECH is a disruptive delivery technology platform that promotes healthier ingestion methods and lower dosages, while increasing overall effectiveness of lipophilic active molecules. Lexaria Bioscience Corp. has multiple patents pending in over 40 countries and already has patents granted in the U.S. and Australia for the utilization of its signature DehydraTECH technology. The technology increases intestinal absorption rates, allowing for more rapid delivery to the bloodstream of various orally administered bioactive compounds, such as cannabinoids, vitamins and non-steroid anti-inflammatory drugs.

For more information, visit the company’s website at www.LexariaBioscience.com

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at www.nnw.fm/LXRP

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Marijuana Company of America Inc. (MCOA) Realizing Dream of Farm-to-Consumer Verticals in Cannabis Industry

• Marijuana Company of America Inc. recently initiated a new push into tetrahydrocannabinol (THC) product development through an LOI with Natural Plant Extract of California
• Analysts predict that California’s cannabis market will reach $5.1 billion in sales this year and $7.7 billion by 2022
• Recreational use marijuana is expected to be the prime driver in the market

During a crucial year for expansion in California’s cannabis market, Marijuana Company of America Inc. (OTCQB: MCOA) is lighting the pathway toward achieving its goal of farm-to-consumer vertical collaboration among its subsidiaries in the cannabis space.

MCOA recently uplisted its trading tier to the OTCQB Venture Marketplace, as well as improving its hempSMART brand presence as cannabidiol (CBD) oils and infused products gain increasing gravitas among the health and wellness community.

This month, the company added a push into the tetrahydrocannabinol (THC) product space by announcing an LOI with Natural Plant Extract of California (“NPE”) and its subsidiary, Northern Lights Distribution, LLC, to establish a joint venture that would operate a California cannabis delivery service named Viva Buds.

“This partnership will enable MCOA to establish itself as a major player in the Cannabis arena,” CEO Donald Steinberg stated in a news release about the agreement (http://nnw.fm/Hg36e). “The NPE team has a great deal of industry knowledge and has an industry disruptive business model. This is a huge strategic move for MCOA!”

Although California is more than a year into its legalization of recreational marijuana use, regulatory differences between the state’s local community markets can make getting cannabis products to consumers challenging. At the same time, the ongoing federal view of cannabis as a restricted plant has limited transportation contracts to companies that don’t have federal contracts, leaving the door open to potential competition in the space such as the proposed Viva Buds delivery service.

Data analysts at industry advisory firm Cannabis Business Plan are forecasting a California cannabis market with $7.7 billion in annual sales by 2022, with 61.5 percent of the overall market driven by recreational use marijuana (http://nnw.fm/ue8aT). Researchers at BDS Analytics predict that sales of cannabis will hit $5.1 billion in California this year due to the fast-moving nature of what is one of the largest cannabis markets in the world (http://nnw.fm/I8fmV). California tax and fee regulators are already celebrating the nearly $350 million in sales and excise tax receipts brought in during the first year of recreational marijuana legalization in the state, even though expectations had been for almost double that amount (http://nnw.fm/FzT8K).

Marijuana Company of America has seen its expectations for a cannabis boom enhanced by regulatory changes in the United States, such as the passage of the 2018 Farm Bill just ahead of year’s end, which allowed hemp to be classified as an agricultural product and paved the way for it to become a farm commodity largely free of drug schedule restrictions, even though components of the plant used for medicinal purposes still have to abide by Food and Drug Administration standards to be approved (http://nnw.fm/yr4Lt).

For more information, visit the company’s website at www.MarijuanaCompanyofAmerica.com

NOTE TO INVESTORS: The latest news and updates relating to MCOA are available in the company’s newsroom at http://nnw.fm/MCOA

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Sharing Services Inc. (SHRV) Changes Name to Sharing Services Global Corporation, Reports Million-Dollar Growth in Sales

• Sales grew by more than $64 million since December 2017 launch of products
• SHRV CEO credits ‘Blue Ocean Strategy’, along with Elepreneur and Elevacity Global subsidiaries, for record performance
• Name change reflects company’s international growth strategy

Sharing Services Global Corporation (OTCQB: SHRV) reported sales of $25.9 million for its fiscal Q3 2018 ended January 31, 2019. Those numbers are $8 million higher than the $17.9 million in revenue reported in the previous quarter (http://nnw.fm/NkM10). SHRV CEO John “JT” Thatch said that the increase was due in part to the company’s implementation of a ‘Blue Ocean Strategy’ in its direct selling market. The company also announced that it has changed its name to Sharing Services Global Corporation to better reflect its international growth strategy (http://nnw.fm/zA5YE).

“Our 2018 Q3 results are continued proof that our ‘Blue Ocean Strategy’ is being implemented and accepted in the direct-selling marketplace,” Thatch said in a news release (http://nnw.fm/NkM10). “At a record-breaking pace, our Elepreneur division continues to execute on our mission to change the direct-selling industry with best-in-class products and services.” SHRV sales have grown by more than $64 million since the December 2017 launch of products through its Elepreneur and Elevacity Global divisions.

SHRV is a Plano, Texas-based diversified holdings company that owns, operates or controls a variety of companies engaged in direct selling through independent sales representatives. It also offers services such as energy, technology and insurance. Its divisions include Elevacity Global LLC and Elepreneur LLC.

In a 14A SEC filing, SHRV said that its recent name change would more accurately reflect the company’s international expansion moves (http://nnw.fm/zUJ7h). The company said in the filing that it was planning to grow both organically and by making strategic acquisitions of businesses and technologies. “The company believes there are excellent growth opportunities outside the United States, including in Canada, Mexico, Europe and Asia,” the filing reads.

For more information, visit the company’s website at www.SHRVInc.com

NOTE TO INVESTORS: The latest news and updates relating to SHRV are available in the company’s newsroom at http://nnw.fm/SHRV

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com